Association between CYP17 T-34C rs743572 and breast cancer risk.

about

Association between CYP17 T-34C rs743572 and breast cancer risk.

Item

http://www.wikidata.org/entity/Q49163775

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Association between CYP17 T-34C rs743572 and breast cancer risk.

@en

Association between CYP17 T-34C rs743572 and breast cancer risk.

@nl

type

Item

label

Association between CYP17 T-34C rs743572 and breast cancer risk.

@en

Association between CYP17 T-34C rs743572 and breast cancer risk.

@nl

prefLabel

Association between CYP17 T-34C rs743572 and breast cancer risk.

@en

Association between CYP17 T-34C rs743572 and breast cancer risk.

@nl

P1476

Association between CYP17 T-34C rs743572 and breast cancer risk.

@en

P2093

Dongyan Guo

http://www.w3.org/2001/XMLSchema#string

Hong Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Sun

http://www.w3.org/2001/XMLSchema#string

Meiyan Gao

http://www.w3.org/2001/XMLSchema#string

Ruiping Li

http://www.w3.org/2001/XMLSchema#string

Wansen Sun

http://www.w3.org/2001/XMLSchema#string

Xi Sun

http://www.w3.org/2001/XMLSchema#string

Xiaofei Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Liu

http://www.w3.org/2001/XMLSchema#string

Zhishu Tang

http://www.w3.org/2001/XMLSchema#string

P2860

CYP17 genotype and breast cancer risk

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study

CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study

The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women

Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.

P304

4200-4213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23688

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29423115

http://www.w3.org/2001/XMLSchema#string

P932

5790532

http://www.w3.org/2001/XMLSchema#string